Eli Lilly Blows Past Expectations On The Back Of Mounjaro, ZepboundInvestors Business Daily • 10/30/25
Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidancePRNewsWire • 10/30/25
Eli Lilly, Walmart to offer first retail pickup option for discounted vials of weight loss drug ZepboundCNBC • 10/29/25
Lilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United StatesPRNewsWire • 10/29/25
What's the Driving Force Behind Eli Lilly's Recent Acquisition Spree?Zacks Investment Research • 10/29/25
LillyDirect and Walmart Pharmacy launch first retail pick-up option with direct-to-consumer pricing for ZepboundPRNewsWire • 10/29/25
Eli Lilly, Nvidia partner to build supercomputer, AI factory for drug discovery and developmentCNBC • 10/28/25
Lilly partners with NVIDIA to build the industry's most powerful AI supercomputer, supercharging medicine discovery and delivery for patientsPRNewsWire • 10/28/25
Healthy Returns: What to expect from Eli Lilly, Merck, Gilead and AbbVie third-quarter earningsCNBC • 10/28/25
Is It Worth Investing in Lilly (LLY) Based on Wall Street's Bullish Views?Zacks Investment Research • 10/28/25
Lilly's Omvoh (mirikizumab-mrkz) approved by U.S. FDA as a single-injection maintenance regimen in adults with ulcerative colitisPRNewsWire • 10/27/25